What to Know about BD Biosciences’ Immunology and Cancer Grantmaking

BD Biosciences isn’t a foundation, but rather a company that awards grants in two disease-related fields, immunology and cancer. Let’s take a closer look.

Basics of Immunology Grants

Immunology is the top priority for this corporate grantmaker, and it awards a total of $140,000 to 14 scientists in this field each year. Grants go toward research and development. The fall 2016 award cycle accepts applications January 1 through July 1, 2016. The spring 2017 award cycle application period runs July 1, 2016 through January 1, 2017.

Grantees in 2015 included work in anti-inflammatory therapy after a stroke, innate memory to bacterial infection, and predicting disease relapse in Pediatric Idiopathic Nephrotic Syndrome. Research areas that you pitch in your abstract and application should include at least one of the following fields:

  • Multicolor flow cytometry
  • Cell signaling
  • Stem cell research
  • Immune function
  • Infectious diseases
  • Neuroscience research

Basics of Cancer Grants

Cancer research receives less funding from BD Biosciences—$100,000 total, spread across 10 scientists per year. There aren’t any restrictions on what types of cancer grantees study. The next deadline is the summer 2016 award cycle, for which applications are accepted through January 31, 2016.

The winter 2016 award cycle application period runs between April 1 and September 1, 2016, and the summer 2017 cycle runs from October 1, 2016 to April 1, 2017. Again, these grants must be used for research purposes only, not for any diagnostic or therapeutic causes. Recent cancer grants have gone toward work in breast cancer stem cell targeting, treatment for refractory cancer, and identifying lung cancer stem cell markers. BD Biosciences also recently funded research into immunotherapy for type 1 diabetes, which was determined to be safe in the first U.S. trial.

General Rules and Procedure

For both grant programs, applications are reviewed by scientists and academic and research institutions. According to the guidelines, “Awards will be based on the application's creativity, content, and innovation, including how the applicant proposes to use BD Biosciences reagents to further his or her research study's goals.” Check out the Abstract Submission Best Practices document for more tips before you apply.

Unfortunately for grantseekers, BD doesn’t publicize the names or contact information of its grants department staff. Questions about the immunology grant program should be directed to grant@bd.com and cancer grant program questions to crgrant@bd.com. BD Biosciences is headquartered in San Jose, California, and the general number is 877-232-8995.

To learn more about this funder, check out IP’s full profile of BD Biosciences: Grants for Disease.